Julia Newman

PrEP-ception: Using PrEP to Reduce HIV Transmission Risk During Conception

By Julia Newman | May 1, 2014 | Comments Off

We don’t have a cure for AIDS yet, but, in 2012, the Food and Drug Administration (FDA) approved daily use of Truvada (an anti-retroviral drug combination containing tenofovir and emtricitabine) for “Pre-Exposure Prophylaxis (PrEP)” to reduce the risk of HIV transmission during sexual intercourse.

Search women's health information:

Keyword Search:

Author:

Order By:

Filter by Category:

Filter by Issue:

Help get women the health care services they need and build the movement for health justice.

Get featured on our podcast, Your Health Unlocked

Help strengthen our voice as advocates today.

You can support our work in many ways:

Julia Newman

Contact Us:

Follow Us:

Get Updates: